Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
The telehealth providers, pharmacy programs, and lifestyle integrations the GLP1Zoom editorial team is actively reviewing — and what we're checking before we publish a recommendation. Nothing on this page carries an affiliate link.
Under review = no recommendation yet.
We publish once the reviewer team finalizes scoring. See how we review providers for the rubric, and /methodology for conflict-of-interest controls.
Verifying cash-pay pricing, prescriber availability across all 50 states, and how Med+ behavioral coaching integrates with brand-name Wegovy fills.
Started · Expected to publish
Auditing the post-FDA-503A formulation change — confirming sterility documentation, lot traceability, and refund policy for affected patients.
Started · Expected to publish
Testing the new "GLP-1 fatigue mode" auto-pace adjustments and whether the activity export plays nicely with the major telehealth dashboards.
Started · Expected to publish
Verifying the cash-pay markup (cost+15% claim), insurance-without-PBM workflow, and shipping reliability for refrigerated pens.
Started · Expected to publish
Re-evaluating prescriber credentialing, response-time SLA, and refund handling under new management before re-listing on /providers.
Started · Expected to publish
Want to suggest a provider for review? Email [email protected]. See also our published provider directory and editorial policy.